Sept 19 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* NUVO PHARMACEUTICALS™ ANNOUNCES SIGNING OF DEFINITIVE AGREEMENTS TO ACQUIRE COMMERCIAL PRODUCTS AND INFRASTRUCTURE FROM ARALEZ PHARMACEUTICALS
* NUVO PHARMACEUTICALS INC - DEAL IMMEDIATELY AND SIGNIFICANTLY ACCRETIVE TO REVENUE AND ADJUSTED EBITDA AFTER CLOSE
* NUVO PHARMACEUTICALS INC - DEAL PROJECTED TO BE ACCRETIVE TO NET INCOME IN 2019
* NUVO PHARMACEUTICALS - THERE WILL BE NO CHANGES TO NUVO SENIOR MANAGEMENT TEAM OR BOARD DUE TO DEAL
* NUVO PHARMACEUTICALS INC - ARALEZ, ALONG WITH ARALEZ PHARMACEUTICALS CANADA INC., HAS COMMENCED VOLUNTARY PROCEEDINGS UNDER CCAA